IRIS BIOTECHNOLOGIES INC
company.status.inactiveCIK 1396238fmd_0GMKB5QN0DXGMX58QG47FDE51JManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2000 to Sep 30, 2016, 36 periods
Latest annual · FY2015
Millions- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (0)
Latest quarter · Q3 FY2016
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2010 to FY2015
- n/m
IRIS BIOTECHNOLOGIES INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.1 million | -$1.2 million | 10-K 2016-03-30 · proof | |
| Net income | -$1.2 million | -$1.2 million | 10-K 2016-03-30 · proof | |
| Cash from operating activities | -$451,280 | -$640,398 | 10-K 2016-03-30 · proof | |
| Free cash flow | -$478,090 | -$647,843 | 10-K 2016-03-30 · proof | |
| Total assets | $53,081 | $331,816 | -84% | 10-K 2016-03-30 · proof |
| Total liabilities | $494,580 | $268,214 | +84.4% | 10-K 2016-03-30 · proof |
| Cash and cash equivalents | $19,839 | $322,929 | -93.9% | 10-K 2016-03-30 · proof |
- What was IRIS BIOTECHNOLOGIES INC's operating income in fiscal 2015?
- IRIS BIOTECHNOLOGIES INC reported operating income of -$1.1 million for fiscal 2015 (the year ended Dec 31, 2015), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was IRIS BIOTECHNOLOGIES INC's net income in fiscal 2015?
- IRIS BIOTECHNOLOGIES INC reported net income of -$1.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was IRIS BIOTECHNOLOGIES INC's cash from operating activities in fiscal 2015?
- IRIS BIOTECHNOLOGIES INC reported cash from operating activities of -$451,280 for fiscal 2015 (the year ended Dec 31, 2015), against -$640,398 the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was IRIS BIOTECHNOLOGIES INC's free cash flow in fiscal 2015?
- IRIS BIOTECHNOLOGIES INC reported free cash flow of -$478,090 for fiscal 2015 (the year ended Dec 31, 2015), against -$647,843 the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are IRIS BIOTECHNOLOGIES INC's total assets?
- As of Dec 31, 2015, IRIS BIOTECHNOLOGIES INC reported total assets of $53,081, against $331,816 a year earlier (-84%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are IRIS BIOTECHNOLOGIES INC's total liabilities?
- As of Dec 31, 2015, IRIS BIOTECHNOLOGIES INC reported total liabilities of $494,580, against $268,214 a year earlier (+84.4%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are IRIS BIOTECHNOLOGIES INC's cash and cash equivalents?
- As of Dec 31, 2015, IRIS BIOTECHNOLOGIES INC reported cash and cash equivalents of $19,839, against $322,929 a year earlier (-93.9%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1396238&period_type=annual&limit=5"Information only, not investment advice.